Human NT2 neural precursor-derived tumor-infiltrating cells as delivery vehicles for treatment of glioblastoma

Human Gene Therapy

Volumn 21, Issue 6, 2010, Pages 683-694

  Zhao, Ying ^a   Wang, Shu ^a,b  

^a INSTITUTE OF BIOENGINEERING AND NANOTECHNOLOGY   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; RETINOIC ACID; THYMIDINE KINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN TISSUE; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CANCER THERAPY; CELL MIGRATION; FEMALE; GENE DELIVERY SYSTEM; GLIOBLASTOMA; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MOUSE; NEURAL STEM CELL; NONHUMAN; TUMOR XENOGRAFT;

ANIMALS; BRAIN; BRAIN NEOPLASMS; GANCICLOVIR; GLIOBLASTOMA; GLIOMA; HUMANS; MALE; MICE; MICE, NUDE; NERVOUS SYSTEM; NERVOUS SYSTEM NEOPLASMS; NEURONS; VEHICLES;

ANIMALIA; MUS; SIMPLEXVIRUS;

EID: 77954996316     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2009.196     Document Type: Article

References (52)

1. Aboody, K.S., Brown, A., Rainov, N.G., Bower, K.A., Liu, S., Yang, W., Small, J.E., Herrlinger, U., Ourednik, V., Black, P.M., Breakefield, X.O., and Snyder, E.Y. (2000). Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc. Natl. Acad. Sci. U.S.A. 97, 12846-12851.
2. Aboody, K.S., Bush, R.A., Garcia, E., Metz, M.Z., Najbauer, J., Justus, K.A., Phelps, D.A., Remack, J.S., Yoon, K.J., Gillespie, S., Kim, S.U., Glackin, C.A., Potter, P.M., and Danks, M.K. (2006). Development of a tumor-selective approach to treat metastatic cancer. PLoS ONE 1, e23.
3. 4-integrin and SDF-Ia-dependent mechanisms. Cancer Biol. Ther. 3, 838-844.
4. Andrews, P.W., Damjanov, I., Simon, D., Banting, G.S., Carlin, C., Dracopoli, N.C., and Fogh, J. (1984). Pluripotent embryonal carcinoma clones derived from the human teratocarcinoma cell line Tera-2: Differentiation in vivo and in vitro. Lab. Invest. 50, 147-162.
5. Balani, P., Boulaire, J., Zhao, Y., Zeng, J., Lin, J., and Wang, S. (2009). High mobility group box2 promoter-controlled suicide gene expression enables targeted glioblastoma treatment. Mol. Ther. 17, 1003-1011.
6. Baselga, J., Maerz, W.J., Moy, D., Miller, W.H., Jr., Castro, L., Reuter, V.E., Yao, T.J., Masui, H., and Dmitrovsky, E. (1993). Over-expression of transforming growth factor a antagonizes the anti-tumorigenic but not the differentiation actions of re-tinoic acid in a human teratocarcinoma cell. Oncogene 8, 3257-3263.
7. Benedetti, S., Pirola, B., Pollo, B., Magrassi, L., Bruzzone, M.G., Rigamonti, D., Galli, R., Selleri, S., Di Meco, F., De Fraja, C., Vescovi, A., Cattaneo, E., and Finocchiaro, G. (2000). Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med. 6, 447-450.
8. Boockvar, J., Kapitonov, D., Kapoor, G., Schouten, J., Counelis, G., Bogler, O., Snyder, E., McIntosh, T., and O'Rourke, D. (2003). Constitutive EGFR signalling confers a motile phe-notype to neural stem cells. Mol. Cell. Neurosci. 24, 1116-1130.
9. Brown, A.B., Yang, W., Schmidt, N.O., Carroll, R., Leishear, K.K., Rainov, N.G., Black, P.M., Breakefield, X.O., and Aboo-dy, K.S. (2003). Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum. Gene Ther. 14, 1777-1785.
10. Dickson, P.V., Hamner, J.B., Burger, R.A., Garcia, E., Ouma, A.A., Kim, S.U., Ng, C.Y., Gray, J.T., Aboody, K.S., Danks, M.K., and Davidoff, A.M. (2007). Intravascular administration of tumor tropic neural progenitor cells permits targeted delivery of interferon-b and restricts tumor growth in a murine model of disseminated neuroblastoma. J. Pediatr. Surg. 42, 48-53.
11. Dimos, J.T., Rodolfa, K.T., Niakan, K.K., Weisenthal, L.M., Mitsumoto, H., Chung, W., Croft, G.F., Saphier, G., Leibel, R., Goland, R., Wichterle, H., Henderson, C.E., and Eggan, K. (2008). Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 321, 1218-1221.
12. Dmitrovsky, E., Moy, D., Miller, W.H., Jr., Li, A., and Masui, H. (1990). Retinoic acid causes a decline in TGF-a expression, cloning efficiency, and tumorigenicity in a human embryonal cancer cell line. Oncogene Res. 5, 233-239.
13. Ehtesham, M., Kabos, P., Kabosova, A., Neuman, T., Black, K.L., and Yu, J.S. (2002). The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res. 62, 5657-5663.
14. Ehtesham, M., Yuan, X., Kabos, P., Chung, N.H., Liu, G., Aka-saki, Y., Black, K.L., and Yu, J.S. (2004). Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia 6, 287-293.
15. Ehtesham, M., Stevenson, C.B., and Thompson, R.C. (2005). Stem cell therapies for malignant glioma. Neurosurg. Focus 19, E5.
16. Erlandsson, A., Larsson, J., and Forsberg-Nilsson, K. (2004). Stem cell factor is a chemoattractant and a survival factor for CNS stem cells. Exp. Cell Res. 301, 201-210.
17. Fenderson, B.A., Andrews, P.W., Nudelman, E., Clausen, H., and Hakomori, S. (1987). Glycolipid core structure switching from globo-to lacto-and ganglio-series during retinoic acidinduced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev. Biol. 122, 21-34.
18. Fillat, C., Carrio, M., Cascante, A., and Sangro, B. (2003). Suicide gene therapy mediated by the herpes simplex virus thymidine kinase gene=ganciclovir system: Fifteen years of application. Curr. Gene Ther. 3, 13-26.
19. Flax, J.D., Aurora, S., Yang, C., Simonin, C., Wills, A.M., Bill-inghurst, L.L., Jendoubi, M., Sidman, R.L., Wolfe, J.H., Kim, S.U., and Snyder, E.Y. (1998). Engraftable human neural stem cells respond to developmental cues, replace neurons, and express foreign genes. Nat. Biotechnol. 16, 1033-1039.
20. Freemantle, S.J., Kerley, J.S., Olsen, S.L., Gross, R.H., and Spi-nella, M.J. (2002). Developmentally-related candidate retinoic acid target genes regulated early during neuronal differentiation of human embryonal carcinoma. Oncogene 21, 2880-2889.
21. Glass, R., Synowitz, M., Kronenberg, G., Walzlein, J.H., Mar-kovic, D.S., Wang, L.P., Gast, D., Kiwit, J., Kempermann, G., and Kettenmann, H. (2005). Glioblastoma-induced attraction of endogenous neural precursor cells is associated with improved survival. J. Neurosci. 25, 2637-2646.
22. Hamel, W., and Westphal, M. (1997). The road less travelled: c-Kit and stem cell factor. J. Neurooncol. 35, 327-333.
23. Hara, K., Yasuhara, T., Maki, M., Matsukawa, N., Masuda, T., Yu, S.J., Ali, M., Yu, G., Xu, L., Kim, S.U., Hess, D.C., and Borlongan, C.V. (2008). Neural progenitor NT2N cell lines from teratocarcinoma for transplantation therapy in stroke. Prog. Neurobiol. 85, 318-334.
24. Imitola, J., Raddassi, K., Park, K.I., Mueller, F.J., Nieto, M., Teng, Y.D., Frenkel, D., Li, J., Sidman, R.L., Walsh, C.A., Snyder, E.Y., and Khoury, S.J. (2004). Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1a=CXC chemokine receptor 4 pathway. Proc. Natl. Acad. Sci. U.S.A. 101, 18117-18122.
25. Jurvansuu, J., Zhao, Y., Leung, D.S., Boulaire, J., Yu, Y.H., Ahmed, S., and Wang, S. (2008). Transmembrane protein 18 enhances the tropism of neural stem cells for glioma cells. Cancer Res. 68, 4614-4622.
26. Keyoung, H.M., Roy, N.S., Benraiss, A., Louissaint, A., Jr., Suzuki, A., Hashimoto, M., Rashbaum, W.K., Okano, H., and Goldman, S.A. (2001). High-yield selection and extraction of two promoter-defined phenotypes of neural stem cells from the fetal human brain. Nat. Biotechnol. 19, 843-850.
27. Kim, S.K., Kim, S.U., Park, I.H., Bang, J.H., Aboody, K.S., Wang, K.C., Cho, B.K., Kim, M., Menon, L.G., Black, P.M., and Carroll, R.S. (2006). Human neural stem cells target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression. Clin. Cancer Res. 12, 5550-5556.
28. Kondziolka, D., Wechsler, L., Goldstein, S., Meltzer, C., Thul-born, K.R., Gebel, J., Jannetta, P., DeCesare, S., Elder, E.M., McGrogan, M., Reitman, M.A., and Bynum, L. (2000). Transplantation of cultured human neuronal cells for patients with stroke. Neurology 55, 565-569.
29. Lee, C.M., and Reddy, E.P. (1999). The v-myc oncogene. Onco-gene 18, 2997-3003.
30. Lee, J., Elkahloun, A.G., Messina, S.A., Ferrari, N., Xi, D., Smith, C.L., Cooper, R., Jr., Albert, P.S., and Fine, H.A. (2003). Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: A potential antiglioma cellular vector. Cancer Res. 63, 8877-8889.
31. Lorico, A., Mercapide, J., Soloduschko, V., Alexeyev, M., Fodstad, O., and Rappa, G. (2008). Primary neural stem= progenitor cells expressing endostatin or cytochrome P450 for gene therapy of glioblastoma. Cancer Gene Ther. 15, 605-615.
32. Luo, Y., Cai, J., Liu, Y., Xue, H., Chrest, F.J., Wersto, R.P., and Rao, M. (2002). Microarray analysis of selected genes in neural stem and progenitor cells. J. Neurochem. 83, 1481-1497.
33. Maerz, W.J., Baselga, J., Reuter, V.E., Mellado, B., Myers, M.L., Bosl, G.J., Spinella, M.J., and Dmitrovsky, E. (1998). FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas. Oncogene 17, 761-767.
34. Miletic, H., Fischer, Y., Litwak, S., Giroglou, T., Waerzeggers, Y., Winkeler, A., Li, H., Himmelreich, U., Lange, C., Stenzel, W., Deckert, M., Neumann, H., Jacobs, A.H., and von Laer, D. (2007). Bystander killing of malignant glioma by bone marrow-derived tumor-infiltrating progenitor cells expressing a suicide gene. Mol. Ther. 15, 1373-1381.
35. Miyazono, M., Nowell, P.C., Finan, J.L., Lee, V.M., and Troja-nowski, J.Q. (1996). Long-term integration and neuronal differentiation of human embryonal carcinoma cells (NTera-2) transplanted into the caudoputamen of nude mice. J. Comp. Neurol. 376, 603-613.
36. Moasser, M.M., Khoo, K.S., Maerz, W.J., Zelenetz, A., and Dmitrovsky, E. (1996). Derivation and characterization of retinoid-resistant human embryonal carcinoma cells. Differentiation 60, 251-257.
37. Nelson, P.T., Kondziolka, D., Wechsler, L., Goldstein, S., Gebel, J., DeCesare, S., Elder, E.M., Zhang, P.J., Jacobs, A., McGro-gan, M., Lee, V.M., and Trojanowski, J.Q. (2002). Clonal human (hNT) neuron grafts for stroke therapy: Neuropathol-ogy in a patient 27 months after implantation. Am. J. Pathol. 160, 1201-1206.
38. Newman, M.B., Misiuta, I., Willing, A.E., Zigova, T., Karl, R.C., Borlongan, C.V., and Sanberg, P.R. (2005). Tumorigenicity issues of embryonic carcinoma-derived stem cells: Relevance to surgical trials using NT2 and hNT neural cells. Stem Cells Dev. 14, 29-43.
39. Pleasure, S.J., and Lee, V.M. (1993). NTera 2 cells: A human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 35, 585-602.
40. Przyborski, S.A., Smith, S., and Wood, A. (2003). Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Stem Cells 21, 459-471.
41. Pulkkanen, K.J., and Ylä-Herttuala, S. (2005). Gene therapy for malignant glioma: Current clinical status. Mol. Ther. 12, 585-598.
42. Rainov, N.G. (2000). A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum. Gene Ther. 11, 2389-2401.
43. Roy, N.S., Wang, S., Jiang, L., Kang, J., Benraiss, A., Harrison-Restelli, C., Fraser, R.A., Couldwell, W.T., Kawaguchi, A., Okano, H., Nedergaard, M., and Goldman, S.A. (2000). In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat. Med. 6, 271-277.
44. Saito, A., Sugawara, A., Uruno, A., Kudo, M., Kagechika, H., Sato, Y., Owada, Y., Kondo, H., Sato, M., Kurabayashi, M., Imaizumi, M., Tsuchiya, S., and Ito, S. (2007). All-trans retinoic acid induces in vitro angiogenesis via retinoic acid receptor: Possible involvement of paracrine effects of endogenous vascular endothelial growth factor signaling. Endocrinology 148, 1412-1423.
45. Schanzer, A., Wachs, F.P., Wilhelm, D., Acker, T., Cooper-Kuhn, C., Beck, H., Winkler, J., Aigner, L., Plate, K.H., and Kuhn, H.G. (2004). Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 14, 237-248.
46. Schmidt, N.O., Przylecki, W., Yang, W., Ziu, M., Teng, Y., Kim, S.U., Black, P.M., Aboody, K.S., and Carroll, R.S. (2005). Brain tumor tropism of transplanted human neural stem cells is induced by vascular endothelial growth factor. Neoplasia 7, 623-629.
47. Shimato, S., Natsume, A., Takeuchi, H., Wakabayashi, T., Fujii, M., Ito, M., Ito, S., Park, I.H., Bang, J.H., Kim, S.U., and Yoshida, J. (2007). Human neural stem cells target and deliver therapeutic gene to experimental leptomeningeal medullo-blastoma. Gene Ther. 14, 1132-1142.
48. Spinella, M.J., Freemantle, S.J., Sekula, D., Chang, J.H., Christie, A.J., and Dmitrovsky, E. (1999). Retinoic acid promotes ubiquitination and proteolysis of cyclin D1 during induced tumor cell differentiation. J. Biol. Chem. 274, 22013-22018.
49. Staflin, K., Honeth, G., Kalliomaki, S., Kjellman, C., Edvardsen, K., and Lindvall, M. (2004). Neural progenitor cell lines inhibit rat tumor growth in vivo. Cancer Res. 64, 5347-5354.
50. Sun, L., Lee, J., and Fine, H.A. (2004). Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J. Clin. Invest. 113, 1364-1374.
51. Wang, S., Rosengren, L., Hamberger, A., and Haglid, K. (2001). Antisense inhibition of BCL-2 expression induces retinoic acid-mediated cell death during differentiation of human NT2N neurons. J. Neurochem. 76, 1089-1098.
52. Yuan, X., Hu, J., Belladonna, M.L., Black, K.L., and Yu, J.S. (2006). Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res. 66, 2630-2638.